These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 6432894)
1. The growth hormone responses to L-dopa and TRH in acromegaly. Jialal I; Naidoo C; Nathoo BC; Rajput MC; Joubert SM J Endocrinol Invest; 1984 Jun; 7(3):235-7. PubMed ID: 6432894 [TBL] [Abstract][Full Text] [Related]
2. [Attempt at suppressing the THR-stimulated plasma growth hormone increase with the use of L-dopa in a cromegaly]. Kasperlik-Zaluska A; Migdalska B; Wiśniewska-Woźniak T; Kaniewski M Endokrynol Pol; 1977; 28(1):31-5. PubMed ID: 401736 [No Abstract] [Full Text] [Related]
3. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly. Hanew K; Aida M; Tano T; Yoshinaga K Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727 [TBL] [Abstract][Full Text] [Related]
4. [Comparison with growth hormone responses to various drugs or substances in patients with active acromegaly (author's transl)]. Takahara J; Ogawa N; Hosogi H; Aoki Y; Yamauchi J Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):803-12. PubMed ID: 821792 [TBL] [Abstract][Full Text] [Related]
5. [Abnormal reaction of GH to TRH and l-dopa stimulation in acromegaly]. Haniu K; Taya T; Aida M; Yoshinaga K Horumon To Rinsho; 1976 Nov; 24(11):1145-50. PubMed ID: 827402 [No Abstract] [Full Text] [Related]
7. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations]. De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567 [TBL] [Abstract][Full Text] [Related]
8. Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man. Müller EE; Salerno F; Cocchi D; Locatelli V; Panerai AE Clin Endocrinol (Oxf); 1979 Dec; 11(6):645-56. PubMed ID: 119594 [TBL] [Abstract][Full Text] [Related]
9. [Plasma prolactin and GH response after thyrotropin-releasing hormone (TRH), L-DOPA and sulpiride in patients with senile dementia of Alzheimer type]. Fujita M; Toyoda K; Motomura N; Kuroda K; Shimizu T Rinsho Shinkeigaku; 1985 Jul; 25(7):767-75. PubMed ID: 3935351 [No Abstract] [Full Text] [Related]
10. Dynamic evaluation of growth hormone (GH) and prolactin (hPRL) secretion in active acromegaly with high and low GH output. Tolis G; Kovacs L; Friesen H; Martin JB Acta Endocrinol (Copenh); 1975 Feb; 78(2):251-7. PubMed ID: 803748 [TBL] [Abstract][Full Text] [Related]
11. Lack of effect of thyroid hormones on the growth hormone response to thyrotropin-releasing hormone in acromegaly. Carlson HE; Sowers JR; Rand RW Metabolism; 1977 Jul; 26(7):801-5. PubMed ID: 405552 [TBL] [Abstract][Full Text] [Related]
12. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas. Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021 [TBL] [Abstract][Full Text] [Related]
13. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine. Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270 [TBL] [Abstract][Full Text] [Related]
14. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients. Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427 [TBL] [Abstract][Full Text] [Related]
15. The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. Alster DK; Bowers CY; Jaffe CA; Ho PJ; Barkan AL J Clin Endocrinol Metab; 1993 Sep; 77(3):842-5. PubMed ID: 8370708 [TBL] [Abstract][Full Text] [Related]
16. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas. Chang CC; Chen FW; Hsieh HC Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734 [TBL] [Abstract][Full Text] [Related]
17. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy. Hoyte KM; Martin JB J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457 [TBL] [Abstract][Full Text] [Related]
18. Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly. Maeda K Kobe J Med Sci; 1976 Dec; 22(4):263-72. PubMed ID: 829578 [No Abstract] [Full Text] [Related]
19. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue. Peracchi M; Molteni N; Cantalamessa L; Bardella MT; Peracchi G; Orsatti A; Faggioli P; Bianchi PA Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643 [TBL] [Abstract][Full Text] [Related]
20. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa. Maeda K; Kato Y; Chihara K; Ogo S; Iwasaki Y J Clin Endocrinol Metab; 1975 Aug; 41(2):408-11. PubMed ID: 239963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]